Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Borapetoside E

Inquiry
Cat. No.: OB0425LY-327
Synonyms: 151200-49-6; Methyl (1S,2R,7S,8S,9R)-8-[(2R)-2-(furan-3-yl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-2,8-dimethyl-10-oxo-11-oxatricyclo[7.2.1.02,7]dodec-3-ene-3-carboxylate; 1,4-Methano-2-benzoxepin-9-carboxylic acid, 5-[(2R)-2-(3-furanyl)-2-(beta-D-glucopyranosyloxy)ethyl]-1,3,4,5,5a,6,7,9a-octahydro-5,9a-dimethyl-3-oxo-, methyl ester, (1S,4R,5S,5aS,9aR)-
Size: 50 mg; 100 mg; 250 mg
CAS No.: 151200-49-6
Compound CID: 124578182
Borapetoside E

Specification

Description: Borapetoside E is a high-qulity product isolated from T. crispa. It has anti-cancer properties and the ability to modulate immune system responses.
Formula Weight: 536.57
Applications: Borapetoside E can be used to improve hyperglycemia, insulin resistance, hepatic steatosis, hyperlipidemia, and oxygen consumption in obese mice.
Storage: Storage at -20°C.
Formula: C27H36O11
Source: T. crispa
Appearance: Solid
Purity: ≥95%
Pathway: Metabolic enzyme/Protease
Target: Fatty acid synthase (FASN)

Library Information

Inquiry

Copyright © Protheragen. All rights reserves.